UC BON.CAP.CERT. 03/25 OMV/ DE000HD7K326 /
06/01/2025 21:46:39 | Var.-0.040 | Denaro21:59:04 | Lettera21:59:04 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
55.870EUR | -0.07% | 55.660 Quantità in denaro: 1,000 |
56.000 Quantità in lettera: 1,000 |
OMV AG | - - | 28/03/2025 | Call |
GlobeNewswire
26/03/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center